help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 51, No. 5 1123-1127
doi:10.1210/jcem-51-5-1123
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAMAI, H.
Right arrow Articles by NAGATAKI, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAMAI, H.
Right arrow Articles by NAGATAKI, S.

Changes in Thyroid Function in Euthyroid Subjects with a Family History of Graves' Disease: A Foliow-Up Study of 69 Patients*

HAJIME TAMAI, NORIYUKI OHSAKO, KOHICHIRO TAKENO, OSAMU FUKINO, HIDEAKI TAKAHASHI, KANJI KUMA, LINDY F. KUMAGAI and SHIGENOBU NAGATAKI

Department of Psychosomatic Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan; Kuma Hospital Kobe, Japan;
Department of Internal Medicine, School of Medicine, University of California-Davis Davis, California;
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo Tokyo, Japan

TRH tests were performed in 206 clinically and biochemically euthyroid relatives of patients with Graves' disease. In 117 of the 206, T3 suppression tests were performed. Results revealed that 56 of the 206 (27.1%) showed abnormal responses to TRH. Twenty-nine of these (14.1%) revealed absent or decreased responses, and 27 (13.1%) revealed augmented responses to TRH. Eight of the 117 (6.8%) were T3 nonsuppressible. These eight subjects consisted of 4 subjects out of 17 hyporesponders and 4 subjects out of 90 normal responders. The majority of suppressible subjects (86 among 109) demonstrated normal responses to TRH. Sixty-nine of the 206 subjects were followed for 6 months to 5 yr to observe changes in their thyroid functions. Among all 69 subjects, 3 became clinically thyrotoxic 12, 12, and 18 months after their initial visit, respectively, and 2 became clinically hypothyroid 2 yr after their initial visit. Since 69 subjects were clinically and biochemically euthyroid and had no goiter or exophthalmos at their initial visit, the incidence of thyrotoxicosis or hypothyroidism in these subjects could be considered to be remarkably high. It is of interest that the 3 thyrotoxic patients were TRH hyporesponders at their first visit. One patient was T3 suppressible; T3 suppression tests were not performed in the other 2 patients at their initial visit. There was no abnormality in the first TRH test in 2 relatives who became hypothryoid.

It is suggested that 1) among euthyroid relatives with a family history of Graves' disease, there are many with abnormalities in TRH responsiveness and T3 suppressibility, 2) nonsuppressible subjects are more likely to be TRH hyporesponders and vice versa, 3) hyperthyroidism or hypothyroidism occurs frequently in euthyroid relatives with a family history of Graves' disease, and 4) thyrotoxicosis occurs frequently in TRH-hyporesponders, and hypothyroidism occurs in the others.

* This work was presented at the Eighth International Thyroid Congress, February 3-8, 1980, Sydney, Australia.

Received April 14, 1980.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer
Joint Genetic Susceptibility to Type 1 Diabetes and Autoimmune Thyroiditis: from Epidemiology to Mechanisms
Endocr. Rev., October 1, 2008; 29(6): 697 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Ban, D. A. Greenberg, T. F. Davies, E. Jacobson, E. Concepcion, and Y. Tomer
'Linkage Analysis of Thyroid Antibody Production: Evidence for Shared Susceptibility to Clinical Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3589 - 3596.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Y. Tomer and T. F. Davies
Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function
Endocr. Rev., October 1, 2003; 24(5): 694 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Tomer, D. A. Greenberg, G. Barbesino, E. Concepcion, and T. F. Davies
CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1687 - 1693.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Barbesino, Y. Tomer, E. S. Concepcion, T. F. Davies, and D. A. Greenberg
Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease. II. Selected Gender-Related Genes and the X-Chromosome
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3290 - 3295.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Barbesino, Y. Tomer, E. Concepcion, T. F. Davies, and D. A. Greenberg the International Consortium
Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease: 1. Selected Immunoregulatory Genes
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1580 - 1584.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society